Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Akari Therapeutics PLC AKTX

Healthcare Biotechnology
Akari Therapeutics, Plc is a late-stage biotechnology company. The Company is developing advanced therapies for autoimmune and inflammatory diseases. Its lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activation and leukotriene B4 (LTB4) activity. Its pipeline includes a Phase 3 clinical trial program investigating nomacopan for pediatric... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:AKTX)

Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024

GlobeNewswire 4 days ago

Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights

GlobeNewswire April 1, 2024

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates VIVK, MINM, SDPI, AKTX

PR Newswire March 18, 2024

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates VIVK, MINM, SDPI, AKTX

Accesswire March 16, 2024

Kuehn Law Encourages VIVK, MINM, SDPI, and AKTX Investors to Contact Law Firm

PR Newswire March 15, 2024

Lifshitz Law PLLC Announces Investigations of CHRD, SDPI, VIVK, and AKTX

Accesswire March 8, 2024

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AKTX, HES, TGAN, NS

PR Newswire March 5, 2024

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Akari Therapeutics, Plc Merger

Newsfile March 5, 2024

AKTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Akari Therapeutics, Plc Is Fair to Shareholders

Business Wire March 5, 2024
View More News ››

Opinion & Analysis (NDAQ:AKTX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:AKTX)

Excellent YT coverage on Akari!

https://youtu.be/KTwztpoUB1I?si=mRfnI9EC3bYyiNxt
BryceCanada - November 6, 2023

RE:Rumour Mill Whispers..

http://investor.akaritx.com/static-files/50c90eba-430c-4e52-b500-9462bb00ada8
InsideTweeter - December 11, 2021

Rumour Mill Whispers..

Watch this..!!  Market cap $75M - Robust Pipeline - Acquisition value of similar companies in complement space with similar...
InsideTweeter - December 11, 2021

it's a buy today for me

at $4.25 per share,so glta.
coolfooldumbguy - April 23, 2019

it's a sell today for me

I am too busy day trading stocks right now,so glta but there is no time for me to post all of my buy & sells anymore for you guys.
coolfooldumbguy - March 14, 2019

RE:Been strong all day..............

YYEEEHHHAAA.............$ 11.20 high ......15 minutes to the close.!!!!!!!!!!!!!! SSSSSSAAAAAWWWWWEEEETTTT !!!!!!!!!!!!!!!!!!!!!!!!
Iseneschal - March 31, 2017
View more Bullboard ››

Anfield Energy Inc

Anfield Energy Inc

Anfield Energy Inc. is a Canada-based uranium and vanadium development and near-term production company. A key asset in the ...
View More »